Xylyx Bio offers advanced lung models to accelerate COVID-19-related drug development

Xylyx Bio offers advanced lung models to accelerate COVID-19-related drug development

Xylyx Bio, a pioneer in advanced biological systems for drug development, today announced availability of products that recreate the lung environment in vitro to provide a predictive model that brings much-needed insight into the efficacy of COVID-19-related drug candidates. Read more >>

Share this post